[NEW YORK] Johnson & Johnson raised US prices on around two dozen prescription drugs on Thursday, including the psoriasis treatment Stelara, prostate cancer drug Zytiga and blood thinner...
[HONG KONG] There may be such a thing as a free lunch in China's pharmaceutical industry. It turns out it's not an unlimited buffet, though.
[LONDON] European companies aren't alone in their Brexit pain. Pfizer Inc., the US-based drug behemoth, says its costs for dealing with the upcoming split will reach US$100 million.